Literature DB >> 8341502

The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.

S M Malinowski1, J S Pulido, N E Goeken, C K Brown, J C Folk.   

Abstract

PURPOSE: To establish a human leukocyte antigen (HLA) association in a homogeneous population of patients with pars planitis.
METHODS: A strict set of inclusion parameters was established for the diagnosis of pars planitis. Forty patients with pars planitis who met these criteria underwent HLA analysis of class I and II phenotypes.
RESULTS: HLA-B8 was present in 15 (37.5%) of 40 patients versus 85 (19.7%) of 431 controls (relative risk, 2.44; P = 0.011). HLA-B51 was present in 9 (22.5%) of 40 patients versus 51 (11.8%) of 431 controls (relative risk, 2.16; P = 0.049). HLA-DR2 was present in 27 (67.5%) of 40 patients versus 121 (28.0%) of 431 controls (relative risk, 5.32; P < 0.0001). HLA-DR2 has been associated with multiple sclerosis (MS). Exclusion of five patients with pars planitis in whom MS subsequently developed did not change the significance of these findings.
CONCLUSIONS: The strongest association of pars planitis with HLA-DR2 and the temporal development of MS in some patients with pars planitis further supports an association between pars planitis and MS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341502     DOI: 10.1016/s0161-6420(93)31505-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Intermediate uveitis of pars planitis type in identical twins. Report of a case.

Authors:  J Biswas; S R Raghavendran; R Vijaya
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

Authors:  B van Kooij; M Canninga van Dijk; J de Boer; V Sigurdsson; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  [Bilateral uveitis intermedia. A 15-year clinical course].

Authors:  H D Ayertey; J F Jordan; P Walter; R Brunner
Journal:  Ophthalmologe       Date:  2003-06-18       Impact factor: 1.059

4.  HLA typing of a Hong Kong Chinese family with intermediate uveitis.

Authors:  A C Browning; D Calladine; N Collins; A W Harmer; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

5.  Ultrasound biomicroscopic imaging in intermediate uveitis.

Authors:  G Häring; B Nölle; B Wiechens
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

Review 6.  [Uveitis in multiple sclerosis : Overview and perspectives].

Authors:  A L Hildebrandt; F Mackensen
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

7.  Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City.

Authors:  G Ortega-Larrocea; L Arellanes-Garcia
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

8.  Eye disorders in patients with multiple sclerosis: natural history and management.

Authors:  Jennifer Graves; Laura J Balcer
Journal:  Clin Ophthalmol       Date:  2010-12-06

9.  Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

10.  Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.

Authors:  Madison Kyger; Aneta Worley; Jianya Huan; Hugh McDowell; W Clay Smith; Gregory G Burrows; Mary J Mattapallil; Rachel R Caspi; Grazyna Adamus
Journal:  Transl Vis Sci Technol       Date:  2013-02-05       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.